eMedicine Specialties > General Surgery > Abdomen

Pyogenic Hepatic Abscesses

Author: Todd A Nickloes, DO, Assistant Professor of Surgery, Division of Trauma/Critical Care, University of Tennessee Medical Center
Coauthor(s): Brian Reed, MD, Staff Physician, Department of Surgery, University of Tennessee Medical Center; LaMar O Mack, MD, Staff Physician, Department of Surgery, University of Tennessee Medical Center; Mohamed Akoad, MD, Liver Transplant Surgeon, Division of Hepatobiliary and Liver Transplantation, Department of Surgery, Veterans Administration Pittsburgh Healthcare System; Richard W Golub, MD, FACS, Consulting Surgeon, Sarasota Memorial Hospital and Doctors Hospital; Consulting Surgeon, Intercoastal Medical Group
Contributor Information and Disclosures

Updated: Jan 23, 2009

Introduction

Pyogenic hepatic abscesses are uncommon conditions that present diagnostic and therapeutic challenges to physicians. If left untreated, these lesions are invariably fatal.

Related eMedicine topics:
Amebiasis [Infectious Diseases]
Amebiasis [Pediatrics: General Medicine]
Amebic Hepatic Abscesses
Liver Abscess

History of the Procedure

Liver abscesses have been recognized since the age of Hippocrates. In 1883, Koch described the amoebae as a cause of liver abscess. In 1938, Ochsner and Debakey published the largest series of pyogenic and amebic liver abscesses in the literature.1 Since the late 20th century, percutaneous drainage has become a useful therapeutic option.2,3,4,5,6

Frequency

The incidence of pyogenic liver abscess has remained unchanged since just prior to the mid-20th century. In the United States, the incidence of pyogenic liver abscess is estimated to be 8-15 cases per 100,000 persons. This figure is considerably higher in countries where health care is not readily available. Studies indicate that the male-to-female ratio is approximately 2:1; the problem occurs most commonly in the fourth to sixth decade of life.7

Etiology

Biliary disease8

Biliary disease accounts for 21-30% of reported cases.3,7,9 Extrahepatic biliary obstruction leading to ascending cholangitis and abscess formation is the most common cause7,9 and is usually associated with choledocholithiasis, benign and malignant tumors,4 or postsurgical strictures. Biliary-enteric anastomoses (choledochoduodenostomy or choledochojejunostomy) have also been associated with a high incidence of liver abscesses.2,9 Biliary complications (eg, stricture, bile leak) after liver transplantation are also recognized causes of pyogenic liver abscesses.

Infection via the portal system (portal pyemia)

The infectious process originates within the abdomen and reaches the liver by embolization or seeding of the portal vein. With the liberal use of antibiotics for intra-abdominal infections, portal pyemia is now a less frequent cause of pyogenic liver abscesses but still accounts for 20% of cases.7 Appendicitis and pylephlebitis are the predominant causes. However, any source of intra-abdominal abscess, such as acute diverticulitis, inflammatory bowel disease, and perforated hollow viscus, can lead to portal pyemia and hepatic abscesses.

Hematogenous (via the hepatic artery)

This infectious process results from seeding of bacteria into the liver in cases of systemic bacteremia from bacterial endocarditis, urinary sepsis, or following intravenous drug abuse.4

Blunt or penetrating trauma and liver necrosis from inadvertent vascular injury during laparoscopic cholecystectomy are recognized causes of liver abscess.7 In addition, transarterial embolization and cryoablation of liver masses are now recognized as new etiologies of pyogenic abscesses.10

Cryptogenic

No cause is found in approximately half of the cases. However, the incidence is increased in patients with diabetes or metastatic cancer. Patients with repeated cryptogenic liver abscesses should undergo biliary and gastrointestinal evaluation.7

Related eMedicine topics:
Cholangitis [Emergency Medicine]
Cholangitis [Gastroenterology]
Cholangitis, Recurrent Pyogenic

Pathophysiology

Pyogenic bacteria can gain access to the liver by direct extension from contiguous organs or through the portal vein or hepatic artery. Hepatic clearance of bacteria via the portal system appears to be a normal phenomenon in healthy individuals; however, organism proliferation, tissue invasion, and abscess formation can occur with biliary obstruction, poor perfusion, or microembolization.

Microbiology

The organisms isolated most often are included below. Most abscesses contain more than 1 organism and frequently are of biliary or enteric origin. Blood culture results are positive in 33-65% of cases,7 with positive results from abscess cultures reported in 73-100% of series.7,9 Escherichia coli is the most common organism isolated in western series, while Klebsiella pneumoniae has recently emerged as a common isolate in patients with diabetes in Taiwan.11,12,13

The most common microorganisms isolated from blood and abscess cultures are as follows7,9 :

  • E coli - 33%
  • K pneumoniae - 18%
  • Bacteroides species - 24%
  • Streptococcal species - 37%
  • Microaerophilic streptococci - 12%

Presentation

The clinical presentation of liver abscess is insidious; many patients have symptoms for weeks prior to presentation. Fever and right upper quadrant pain are the most common complaints. Pain is reported in as many as 80% of patients and may be associated with pleuritic chest pain or right shoulder pain. Symptoms are often misdiagnosed as acute cholecystitis. Fever occurs in 87-100% of patients and is usually associated with chills and malaise.9 Anorexia, weight loss, and mental confusion are also common symptoms. Physical examination findings are most notable for right upper quadrant tenderness. Hepatomegaly, liver mass, and jaundice are also common. Occasionally, patients may present with rales, pleural effusion, friction rub, or pulmonary consolidation. Rarely, patients are admitted with sepsis and peritonitis from intraperitoneal rupture of the abscess. The following table summarizes the signs and symptoms of pyogenic liver abscess.

Symptoms and Signs of Pyogenic Liver Abscess9,14

Open table in new window

Table
SymptomsPercentageSignsPercentage
Abdominal pain89-100Normal findings38
Fever67-100Right upper quadrant tenderness41-72
Chills33-88Hepatomegaly51-92
Anorexia38-80Mass17-18
Weight loss25-68Jaundice23-43
Cough11-28Chest findings11-48
Pleuritic chest pain9-24
SymptomsPercentageSignsPercentage
Abdominal pain89-100Normal findings38
Fever67-100Right upper quadrant tenderness41-72
Chills33-88Hepatomegaly51-92
Anorexia38-80Mass17-18
Weight loss25-68Jaundice23-43
Cough11-28Chest findings11-48
Pleuritic chest pain9-24


Indications

Presently, most liver abscesses are treated with antibiotics and catheter drainage under ultrasonographic or computed tomography (CT) scan guidance.

The 5 indications for surgical drainage are as follows:

  • Abscess not amenable to percutaneous drainage secondary to location
  • Coexistence of intra-abdominal disease that requires operative management
  • Failure of antibiotic therapy
  • Failure of percutaneous aspiration
  • Failure of percutaneous drainage

Contraindications

Relative contraindications to surgery include the following:

  • Multiple abscesses
  • Polymicrobial infection
  • Presence of associated malignancy or immunosuppressive disease
  • Coexistence of other multiple and/or complicated medical problems or conditions

More on Pyogenic Hepatic Abscesses

Overview: Pyogenic Hepatic Abscesses
Workup: Pyogenic Hepatic Abscesses
Treatment: Pyogenic Hepatic Abscesses
Follow-up: Pyogenic Hepatic Abscesses
Multimedia: Pyogenic Hepatic Abscesses
References

References

  1. Ochsner A, DeBakey M, Murray S. Pyogenic abscess of the liver. Am J Surg. 1938;40:292.

  2. Gerzof SG, Johnson WC, Robbins AH, et al. Intrahepatic pyogenic abscesses: treatment by percutaneous drainage. Am J Surg. Apr 1985;149(4):487-94. [Medline].

  3. Kandel G, Marcon NE. Pyogenic liver abscess: new concepts of an old disease. Am J Gastroenterol. Jan 1984;79(1):65-71. [Medline].

  4. Rintoul R, O'Riordain MG, Laurenson IF, et al. Changing management of pyogenic liver abscess. Br J Surg. Sep 1996;83(9):1215-8. [Medline].

  5. Seeto RK, Rockey DC. Pyogenic liver abscess. Changes in etiology, management, and outcome. Medicine (Baltimore). Mar 1996;75(2):99-113. [Medline].

  6. Stain SC, Yellin AE, Donovan AJ, et al. Pyogenic liver abscess. Modern treatment. Arch Surg. Aug 1991;126(8):991-6. [Medline].

  7. Branum GD, Tyson GS, Branum MA, et al. Hepatic abscess. Changes in etiology, diagnosis, and management. Ann Surg. Dec 1990;212(6):655-62. [Medline][Full Text].

  8. Chu KM, Fan ST, Lai EC, et al. Pyogenic liver abscess. An audit of experience over the past decade. Arch Surg. Feb 1996;131(2):148-52. [Medline].

  9. Gyorffy EJ, Frey CF, Silva J Jr, et al. Pyogenic liver abscess. Diagnostic and therapeutic strategies. Ann Surg. Dec 1987;206(6):699-705. [Medline][Full Text].

  10. Rockey D. Hepatobiliary infections. Curr Opin Gastroenterol. May 1999;15(3):229-33. [Medline].

  11. Tsai FC, Huang YT, Chang LY, et al. Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis. Oct 2008;14(10):1592-600. [Medline][Full Text].

  12. Pastagia M, Arumugam V. Klebsiella pneumoniae liver abscesses in a public hospital in Queens, New York. Travel Med Infect Dis. Jul 2008;6(4):228-33. [Medline].

  13. Cheng HC, Chang WL, Chen WY, et al. Long-term outcome of pyogenic liver abscess: factors related with abscess recurrence. J Clin Gastroenterol. Nov-Dec 2008;42(10):1110-5. [Medline].

  14. Giorgio A, de Stefano G, Di Sarno A, et al. Percutaneous needle aspiration of multiple pyogenic abscesses of the liver: 13-year single-center experience. AJR Am J Roentgenol. Dec 2006;187(6):1585-90. [Medline].

  15. Hashimoto L, Hermann R, Grundfest-Broniatowski S. Pyogenic hepatic abscess: results of current management. Am Surg. May 1995;61(5):407-11. [Medline].

  16. Benedetti NJ, Desser TS, Jeffrey RB. Imaging of hepatic infections. Ultrasound Q. Dec 2008;24(4):267-78. [Medline].

  17. Rubinson HA, Isikoff MB, Hill MC. Diagnostic imaging of hepatic abscesses: a retrospective analysis. AJR Am J Roentgenol. Oct 1980;135(4):735-45. [Medline].

  18. Ferrucci JT Jr, vanSonnenberg E. Intra-abdominal abscess. Radiological diagnosis and treatment. JAMA. Dec 11 1981;246(23):2728-33. [Medline].

  19. Hope WW, Vrochides DV, Newcomb WL, et al. Optimal treatment of hepatic abscess. Am Surg. Feb 2008;74(2):178-82. [Medline].

  20. Chung YF, Tan YM, Lui HF, et al. Management of pyogenic liver abscesses - percutaneous or open drainage?. Singapore Med J. Dec 2007;48(12):1158-65; quiz 1165. [Medline].

  21. Men S, Akhan O, Koroglu M. Percutaneous drainage of abdominal abcess. Eur J Radiol. Sep 2002;43(3):204-18. [Medline].

  22. Yanaga K, Kitano S, Hashizume M, et al. Laparoscopic drainage of pyogenic liver abscess. Br J Surg. Jul 1994;81(7):1022. [Medline].

  23. Siu WT, Chan WC, Hou SM, et al. Laparoscopic management of ruptured pyogenic liver abscess. Surg Laparosc Endosc. Oct 1997;7(5):426-8. [Medline].

  24. Bowers ED, Robison DJ, Doberneck RC. Pyogenic liver abscess. World J Surg. Jan-Feb 1990;14(1):128-32. [Medline].

  25. Chou FF, Sheen-Chen SM, Chen YS, et al. Prognostic factors for pyogenic abscess of the liver. J Am Coll Surg. Dec 1994;179(6):727-32. [Medline].

  26. Wang W, Lee WJ, Wei PL, et al. Laparoscopic drainage of pyogenic liver abscesses. Surg Today. 2004;34(4):323-5. [Medline].

  27. Robles PJ, Lara JG, Lancaster B. Drainage of hepatic amebic abscess successfully treated by laparoscopy. J Laparoendosc Surg. Dec 1994;4(6):451-4. [Medline].

  28. Barakate MS, Stephen MS, Waugh RC, et al. Pyogenic liver abscess: a review of 10 years' experience in management. Aust N Z J Surg. Mar 1999;69(3):205-9. [Medline].

  29. Carrafiello G, Lagana D, Dizonno M, et al. Emergency percutaneous treatment in iatrogenic hepatic arterial injuries. Emerg Radiol. Jul 2008;15(4):249-54. [Medline].

Further Reading

Keywords

pyogenic hepatic abscess, abscess, metronidazole, clindamycin, abscess drainage, abscess liver, liver abscess, drain abscess, biliary disease, biliary obstruction, cholangitis, choledocholithiasis, malignant tumors, benign tumors, post-surgical strictures, postsurgical strictures, biliary-enteric anastomoses, choledochoduodenostomy, portal pyemia, appendicitis, pylephlebitis, diverticulitis, inflammatory bowel disease, proctitis, systemic septicemia, pyogenic bacteria

Contributor Information and Disclosures

Author

Todd A Nickloes, DO, Assistant Professor of Surgery, Division of Trauma/Critical Care, University of Tennessee Medical Center
Todd A Nickloes, DO is a member of the following medical societies: American College of Osteopathic Surgeons, American Medical Association, American Osteopathic Association, Association for Academic Surgery, Eastern Association for the Surgery of Trauma, Society of Critical Care Medicine, Society of Laparoendoscopic Surgeons, Southeastern Surgical Congress, and Southern Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Brian Reed, MD, Staff Physician, Department of Surgery, University of Tennessee Medical Center
Brian Reed, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, and American Medical Association
Disclosure: Nothing to disclose.

LaMar O Mack, MD, Staff Physician, Department of Surgery, University of Tennessee Medical Center
LaMar O Mack, MD is a member of the following medical societies: American Urological Association, National Medical Association, and Student National Medical Association
Disclosure: Nothing to disclose.

Mohamed Akoad, MD, Liver Transplant Surgeon, Division of Hepatobiliary and Liver Transplantation, Department of Surgery, Veterans Administration Pittsburgh Healthcare System
Disclosure: Nothing to disclose.

Richard W Golub, MD, FACS, Consulting Surgeon, Sarasota Memorial Hospital and Doctors Hospital; Consulting Surgeon, Intercoastal Medical Group
Richard W Golub, MD, FACS is a member of the following medical societies: American College of Gastroenterology, American College of Surgeons, American Society for Gastrointestinal Endoscopy, American Society of Colon and Rectal Surgeons, Association for Academic Surgery, Association for Surgical Education, Crohns and Colitis Foundation of America, Society for Surgery of the Alimentary Tract, and Society of American Gastrointestinal and Endoscopic Surgeons
Disclosure: Nothing to disclose.

Medical Editor

Alex Jacocks, MD, Program Director, Professor, Department of Surgery, University of Oklahoma School of Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

David L Morris, MD, PhD, Professor, Department of Surgery, St George Hospital, University of New South Wales, Australia
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA, Vice Chairman, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital
John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract
Disclosure: AMGEN Royalty Other; AstraZeneca Grant/research funds Other

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.